Nabriva Therapeutics Hires Will Sargent as Vice President of Commercial Strategy and Investor Relations
VIENNA, Austria and KING OF PRUSSIA, Pa., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections …